CORIENT CAPITAL PARTNERS, LLC – Edwards Lifesciences Corporation Transaction History
CORIENT CAPITAL PARTNERS, LLC portfolio value:
$1.07M
portfolio value
CORIENT CAPITAL PARTNERS, LLC quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +3.82% | 414 shares | 39K | $82.63 | 11.26K |
Q2 2022 | share | Increase | +10.15% | 1K shares | -127K | $95.09 | 10.84K |
Q1 2022 | share | Increase | +7.15% | 657 shares | -32K | $117.72 | 9.84K |
Q4 2021 | share | Decrease | -45.70% | -7.73K shares | -725K | $130.68 | 9.19K |
Q3 2021 | share | Decrease | -10.21% | -1.92K shares | -37K | $113.21 | 16.92K |
Q2 2021 | share | Increase | +21.74% | 3.36K shares | 657K | $103.57 | 18.85K |
Q1 2021 | share | Increase | +120.50% | 8.46K shares | 655K | $83.64 | 15.48K |
Q4 2020 | share | Increase | +3.20% | 218 shares | 98K | $91.23 | 7.02K |
Q3 2020 | share | Decrease | -2.27% | -158 shares | 62K | $79.82 | 6.80K |
Q2 2020 | share | Increase | +10.68% | 672 shares | 86K | $69.11 | 6.96K |
Q1 2020 | share | Decrease | -10.77% | -759 shares | -154K | $62.87 | 6.29K |
Q4 2019 | share | Increase | +4.86% | 327 shares | 57K | $77.76 | 7.05K |
Q3 2019 | share | Increase | +30.59% | 1.57K shares | 175K | $73.3 | 6.72K |
Q2 2019 | share | Increase | +7.38% | 354 shares | 11K | $61.58 | 5.14K |
Q1 2019 | share | Increase | 0.00% | 4.79K shares | 306K | $63.78 | 4.79K |